These results suggest that TLR4 activation is involved in pathogenesis of esophageal adenocarcinoma, and that increased cyclo-oxygenase 2 activation is a mediator of this activation similar to gastric cancer [25]. This evidence concerns the gene PTGS2 and esophageal adenocarcinoma.